Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study

J Biol Regul Homeost Agents. May-Jun 2020;34(3):757-766. doi: 10.23812/20-250-E-56.

Abstract

The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.

Keywords: COVID-19; SARS-COV-2; clinical study; oxygen-ozone; protocol.

Publication types

  • Editorial
  • Multicenter Study

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / therapy*
  • Humans
  • Oxygen / therapeutic use*
  • Ozone / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2

Substances

  • Ozone
  • Oxygen